Loading clinical trials...
Loading clinical trials...
A Phase 2 Study to Evaluate the Safety and Efficacy of Nab-pacliatxel Plus Gemcitabine in Korean Patients With Metastatic Pancreatic Ductal Adenocarcinoma
Conditions
Interventions
nab-paclitaxel
gemcitabine
Locations
8
South Korea
Dong-A University Hospital
Busan, South Korea
Gyeongsang National University Hospital
Gyeongsang, South Korea
CHA Bundang Medical Center
Seongnam-si, South Korea
Samsung Medical Center
Seoul, South Korea
Asan Medical Center
Seoul, South Korea
Catholic University of Korea, Seoul ST. Mary's Hospital
Seoul, South Korea
Start Date
June 4, 2015
Primary Completion Date
September 30, 2022
Completion Date
September 30, 2022
Last Updated
February 15, 2023
NCT04657068
NCT06445062
NCT04900818
NCT07432633
NCT06005493
NCT04851119
Lead Sponsor
Samsung Medical Center
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions